gut.bmj1d
PTH-43 Improving endoscopy turnaround time and list efficiency through implementation of a multi-faceted improvement plan
Introduction Maximising efficiency in endoscopy in the face of increasing service pressure, demand and complexity of endoscopy is imperative, particularly given the unparalleled impact of the COVID ...
gut.bmj1d
New entity of adult ultra-short coeliac disease: the first international cohort and case–control study
Background Ultra-short coeliac disease (USCD) is defined as villous atrophy only present in the duodenal bulb (D1) with concurrent positive coeliac serology. We present the first, multicentre, ...
gut.bmj1d
Quality of life measurement in gastrointestinal and liver disorders
Conflict of interest statement.Professor Irvine shares ownership of the copyright, together with McMaster University, of the Inflammatory Bowel Disease Questionnaire (IBDQ). Modern medicine has had a ...
gut.bmj2d
Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case–control study
Correspondence to Dr Richard C Pollok, Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, UK; richard.pollok{at}nhs.net Objective Depression is a potential risk ...
gut.bmj2d
Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study
Correspondence to Professor John Dent, Department of Gastroenterology & Hepatology, Royal Adelaide Hospital, Adelaide, SA 5000, Australia; john.dent{at}health.sa.gov.au Objective The aim of this study ...
gut.bmj2d
Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis (DIPPP): a multicentre, double-blind, randomised, controlled trial
Background Recent meta-analyses suggested diclofenac may be superior to indomethacin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). The aim of our study ...
gut.bmj2d
CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer
1 Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Centre, School of Public Health, Nanjing Medical University, Nanjing, ...
gut.bmj2d
Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
Objective To monitor trastuzumab resistance and determine the underlying mechanisms for the limited response rate and rapid emergence of resistance of HER2+ metastatic gastric cancer (mGC). Design ...
gut.bmj3d
PTH-28 Elemental formula and LOFFLEX nutrition therapy; an effective but neglected treatment strategy in Crohn’s disease
Introduction Nutrition therapy in treatment of Chron’s Disease (CD) is not adequately highlighted in adult guidelines despite strong evidence supporting its therapeutic efficacy and thus, this option ...
gut.bmj3d
Bacteria as the cause of ulcerative colitis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj3d
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
1 Departments of Medicine, Surgery, and Pathology, St Mark’s Hospital, London, UK 2 Departments of Internal Medicine, Gastroenterology, and Surgery, University of Bologna, Bologna, Italy Background: ...
gut.bmj3d
The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
Correspondence to Dr Silvio Danese, Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milano, Lombardia, Italy; ...